华神科技(000790.SZ)：拟转让药品上市许可及相关技术暨签署《项目合作协议》

Core Viewpoint - The company aims to enhance the efficiency of its intangible assets and focus on core areas to improve sustainable profitability through the transfer of drug marketing licenses and related technologies [1] Group 1: Asset Management - The company held the 27th meeting of the 13th Board of Directors on December 15, 2025, to approve the proposal for the external transfer of drug marketing licenses and related technologies [1] - The company and Huasheng Pharmaceutical Factory will sign a project cooperation agreement with a partner [1] Group 2: Financial Transactions - Huasheng Pharmaceutical Factory plans to transfer its production technology and marketing license for smokeless moxibustion sticks, valued at RMB 18 million (including tax), to Binjiang Pharmaceutical [1] - The company will invest RMB 4.555556 million to acquire a 10% stake in Shanghai Aixingcheng Technology Co., Ltd., which focuses on the operation and management of medicinal moxibustion-related products [1]